Bespoke Extracts Inc
Bespoke Extracts, Inc., together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States. The company owns, manufactures, and distributes a diverse portfolio of cannabis consumer packaged goods under the Fresh Joints, Doobskis, DutchBlunts, and Wee Joints brand names. It also operates a facility dedicated to the production of ma… Read more
Bespoke Extracts Inc (BSPK) - Total Assets
Latest total assets as of September 2025: $295.57K USD
Based on the latest financial reports, Bespoke Extracts Inc (BSPK) holds total assets worth $295.57K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bespoke Extracts Inc - Total Assets Trend (2010–2024)
This chart illustrates how Bespoke Extracts Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bespoke Extracts Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Bespoke Extracts Inc's total assets of $295.57K consist of 46.0% current assets and 54.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.8% |
| Accounts Receivable | $57.28K | 16.0% |
| Inventory | $32.53K | 9.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $10.00K | 2.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how Bespoke Extracts Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bespoke Extracts Inc's current assets represent 46.0% of total assets in 2024, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 16.8% of total assets in 2024, down from 78.3% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 16.0% of total assets.
Bespoke Extracts Inc Competitors by Total Assets
Key competitors of Bespoke Extracts Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Bespoke Extracts Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Bespoke Extracts Inc generates 3.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bespoke Extracts Inc is currently not profitable relative to its asset base.
Bespoke Extracts Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.11 | 0.07 | 0.19 |
| Quick Ratio | 0.07 | 0.05 | 0.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.68 Million | $ -1.60 Million | $ -547.41K |
Bespoke Extracts Inc - Advanced Valuation Insights
This section examines the relationship between Bespoke Extracts Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 256.41 |
| Latest Market Cap to Assets Ratio | 1.39 |
| Asset Growth Rate (YoY) | 1.3% |
| Total Assets | $359.09K |
| Market Capitalization | $498.21K USD |
Valuation Analysis
Above Book Valuation: The market values Bespoke Extracts Inc's assets above their book value (1.39 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Bespoke Extracts Inc's assets grew by 1.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bespoke Extracts Inc (2010–2024)
The table below shows the annual total assets of Bespoke Extracts Inc from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $359.09K | +1.33% |
| 2023-12-31 | $354.36K | -13.48% |
| 2022-12-31 | $409.59K | +228.94% |
| 2021-12-31 | $124.52K | -25.10% |
| 2020-12-31 | $166.25K | +109.32% |
| 2019-12-31 | $79.42K | -63.86% |
| 2018-12-31 | $219.79K | +41.22% |
| 2017-12-31 | $155.64K | +8818.97% |
| 2016-12-31 | $1.75K | -99.38% |
| 2015-12-31 | $282.69K | -63.65% |
| 2014-12-31 | $777.70K | +12.99% |
| 2013-12-31 | $688.29K | -8.83% |
| 2012-12-31 | $754.96K | +90749.94% |
| 2011-12-31 | $831.00 | -95.20% |
| 2010-12-31 | $17.30K | -- |